S

SynHelix (now Quantoom Biosciences, a Univercells Company)

8 employees

SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biochemistry
synthetic biology
gene therapy
biotechnology
lifesciences
Bioengineering
Recombinant proteins
cell therapy
Protein engineering
Molecular biology
gene synthesis
nanotechnology
Enzyme engineering
enzymology
Surface chemistry
computational biology
bioeconomy
Biotherapeutics
Biocatalysis

Date founded

2019

FAQ